Literature DB >> 9699481

Sequence determinants of DNA binding by the hematopoietic helix-loop-helix transcription factor TAL1: importance of sequences flanking the E-box core.

K A Gould1, E H Bresnick.   

Abstract

TAL1 is a helix-loop-helix transcription factor that is essential for hematopoiesis. In vitro DNA binding site selection experiments have previously identified the preferred binding site for TAL1 heterodimers as AACAGATGGT. TAL1 homodimers do not bind DNA with significant affinity. A subset of other E-box sequences is also bound by TAL1 heterodimers. Here, we present an analysis of TAL1 heterodimer DNA binding specificity, using E-boxes derived from genomic clones, which were isolated by immunoadsorption of K562 erythroleukemia cell chromatin with a TAL1 antibody. We show that TAL1 heterodimer binding to a CAGATG E-box is strongly modulated by nucleotides flanking the E-box. A 10 base pair element consisting of the CAGATG E-box and two flanking nucleotides in both the 5' and 3' direction is sufficient for high-affinity binding. Certain mutations of nucleotides in either the 5' (-1 and -2) or 3' (+1 and +2) direction strongly inhibit binding. The importance of flanking nucleotides also exists in the context of nonpreferred E-boxes recognized by TAL1 heterodimers. Although there are no known target genes for TAL1, the regulatory regions of several genes involved in hematopoiesis contain the preferred E-box CAGATG. However, based on our results, the E-boxes in these potential target genes contain flanking sequences that would be expected to significantly reduce TAL1 heterodimer binding in vitro. Thus, additional stabilizing forces, such as protein-protein interactions between TAL1 heterodimers and accessory factors, may be required to confer high-affinity TAL1 heterodimer binding to such sequences.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9699481      PMCID: PMC6190197     

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  51 in total

1.  Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins.

Authors:  H L Hsu; J T Cheng; Q Chen; R Baer
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

2.  Sequence of the human GATA-1 promoter.

Authors:  L I Zon; S H Orkin
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

3.  A novel DNA-binding protein, HS2NF5, interacts with a functionally important sequence of the human beta-globin locus control region.

Authors:  L T Lam; E H Bresnick
Journal:  J Biol Chem       Date:  1996-12-13       Impact factor: 5.157

4.  Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study.

Authors:  R O Bash; S Hall; C F Timmons; W M Crist; M Amylon; R G Smith; R Baer
Journal:  Blood       Date:  1995-07-15       Impact factor: 22.113

5.  DNA-binding specificity of GATA family transcription factors.

Authors:  M Merika; S H Orkin
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

6.  DNA-binding specificities of the GATA transcription factor family.

Authors:  L J Ko; J D Engel
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

7.  Helix-loop-helix proteins LYL1 and E2a form heterodimeric complexes with distinctive DNA-binding properties in hematolymphoid cells.

Authors:  A Miyamoto; X Cui; L Naumovski; M L Cleary
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

8.  Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo.

Authors:  C Grandori; J Mac; F Siëbelt; D E Ayer; R N Eisenman
Journal:  EMBO J       Date:  1996-08-15       Impact factor: 11.598

9.  Evidence for distinct DNA binding forms of the erythroid-specific transcription factor NF-E2.

Authors:  L T Lam; E H Bresnick
Journal:  Biochemistry       Date:  1995-12-19       Impact factor: 3.162

10.  Novel location and function of a thyroid hormone response element.

Authors:  J Bigler; R N Eisenman
Journal:  EMBO J       Date:  1995-11-15       Impact factor: 11.598

View more
  6 in total

1.  Establishment of distinct MyoD, E2A, and twist DNA binding specificities by different basic region-DNA conformations.

Authors:  T Kophengnavong; J E Michnowicz; T K Blackwell
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

2.  Identification of RANBP16 and RANBP17 as novel interaction partners for the bHLH transcription factor E12.

Authors:  Jun-Ho Lee; Shengli Zhou; Cynthia M Smas
Journal:  J Cell Biochem       Date:  2010-09-01       Impact factor: 4.429

3.  Requirements for utilization of CREB binding protein by hypersensitive site two of the beta-globin locus control region.

Authors:  Kirby D Johnson; Jason E Norton; Emery H Bresnick
Journal:  Nucleic Acids Res       Date:  2002-04-01       Impact factor: 16.971

4.  MESP1 Mutations in Patients with Congenital Heart Defects.

Authors:  Petra Werner; Brande Latney; Matthew A Deardorff; Elizabeth Goldmuntz
Journal:  Hum Mutat       Date:  2016-01-19       Impact factor: 4.878

5.  Molecular hallmarks of endogenous chromatin complexes containing master regulators of hematopoiesis.

Authors:  Ryan J Wozniak; Sunduz Keles; Jesse J Lugus; Ken H Young; Meghan E Boyer; Tuan M Tran; Kyunghee Choi; Emery H Bresnick
Journal:  Mol Cell Biol       Date:  2008-09-08       Impact factor: 4.272

Review 6.  Hematopoietic transcriptional mechanisms: from locus-specific to genome-wide vantage points.

Authors:  Andrew W DeVilbiss; Rajendran Sanalkumar; Kirby D Johnson; Sunduz Keles; Emery H Bresnick
Journal:  Exp Hematol       Date:  2014-05-09       Impact factor: 3.084

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.